title: Lower Erythropoietin Doses and Medicare Payment Reform: Win-Wins for Patients With End-stage Renal Disease.
authors: Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut2Editor at Large, JAMA Internal Medicine.
authors: Robert
authors: R
authors: Steinbrook
mesh_terms: D004921:Erythropoietin; D006801:Humans; D007676:Kidney Failure, Chronic; D006278:Medicare; D011445:Prospective Payment System; D006435:Renal Dialysis; D014481:United States
chemical_list: D004921:Erythropoietin